08/30/2026
She hid her family's life savings inside her daughter's teddy bear.
Not because she was smuggling anything illegal. Because her own government wouldn't let her take money out of the country.
Katalin Karikó was leaving Hungary for good, chasing an idea almost nobody believed in.
She'd grown up poor, the daughter of a butcher, in a house with no running water. But she'd fallen in love with something most people had never heard of.
A molecule called messenger RNA.
Karikó believed you could write your own genetic instructions, inject them into the body, and order it to build its own medicine.
It was a beautiful idea. Almost everyone in science called it a dead end.
The problem was simple. When you injected mRNA into the body, the immune system attacked it instantly, treating it like a foreign invader.
Most researchers gave up. Karikó didn't.
She landed at Temple University in 1985, then moved to the University of Pennsylvania in 1989. That's where she hit a wall that would last for years.
Grant after grant, rejected. Paper after paper, turned down by major journals.
In 1995, Penn made it official. They demoted her, took her off the path to full professor, and cut her pay.
She was given a choice. Drop the mRNA research, or stay demoted.
She stayed on the research. For the rest of her time at Penn, she never earned more than around sixty thousand dollars a year.
Colleagues thought she was wasting her career on a fantasy.
Then, one ordinary day at a photocopier, she started talking with another scientist. An immunologist named Drew Weissman.
They decided to work together.
Together, they found the fix. By changing one small piece of the mRNA molecule, they discovered they could stop the body from attacking it.
The message got through. The cells read the instructions. It worked.
They published the breakthrough in 2005.
Almost nobody noticed.
No major funding. No headlines. No recognition for the woman who had just solved the problem that stood in the way of mRNA medicine.
In 2013, after Penn still wouldn't restore her academic standing, Karikó left the university altogether.
She joined a small, largely unknown company in Germany called BioNTech.
Then, in 2020, the world changed.
A new virus was spreading everywhere, and scientists needed a vaccine faster than one had ever been developed in human history.
The foundation was already sitting there, built over decades by a scientist the field had mostly dismissed.
BioNTech partnered with Pfizer, using the Karikó-Weissman mRNA research to design a COVID vaccine in a matter of days. Moderna built on the same foundation.
Vaccine development that normally takes a decade happened in months.
Billions of doses were given worldwide. Researchers publishing in The Lancet estimated that COVID vaccines prevented close to twenty million deaths in their first year alone.
In 2023, Katalin Karikó received a phone call.
She had won the Nobel Prize in Physiology or Medicine, shared with Drew Weissman, for the exact research that had once cost her a promotion and nearly her career.
The University of Pennsylvania, the same institution that had cut her pay decades earlier, publicly celebrated its Nobel laureate.
She had crossed the world with her family's savings hidden in a teddy bear. She had been rejected, demoted, and dismissed by some of the best minds in her field.
She kept working anyway.
There's one more detail worth knowing. The little girl whose teddy bear once carried a family's entire savings across an ocean grew up to become Susan Francia, a two-time Olympic gold medalist in rowing.
Two very different journeys. One family that refused to stop.